Business
Dr. Kunal Sur, PhD Co-Founder of Arete Bioscience Joins GlucoGuard's Scientific Advisory Board (SAB)
Dr. Kunal Sur, PhD Co-Founder of Arete Bioscience Joins GlucoGuard's Scientific Advisory Board (SAB).
About this update from American Diversified Holdings Corp.
[{"type":"text","content":"\r\n\r\n \r\n \r\n Dr. Kunal Sur, PhD Co-Founder of Arete Bioscience Joins GlucoGuard's Scientific Advisory Board (SAB)\r\n \r\n \r\n\r\n\r\nDr. Kunal Sur, PhD Co-Founder of Arete Bioscience Joins GlucoGuard's Scientific Advisory Board (SAB)\r\n\r\n\r\n\r\nNewsfile Corp.\r\n\r\n\r\nNewsfile Corp\r\n\r\n\r\nDr. Sur's Commitment Aligns Arete Bioscience as GlucoGuard's Ongoing Engineering Partner\r\nDel Mar, California--(Newsfile Corp. - August 4, 2025) - The management team of GlucoGuard, a division of American Diversified Holdings (OTCID: ADHC) (\"ADHC\") announced today that Dr. Kunal Sur, PhD has agreed to join the company's Scientific Advisory Board. Dr. Kunal joins Dr. Stephen Weber, MD and GlucoGuards co-founder Zach Smith to guide GlucoGuard's next developmental phase.\r\nDr. Sur is the co-founder of Arete Bioscience and has been playing an integral role in the development of the prototype engineering for the GlucoGuard Device.\r\n\"Formalizing Dr. Sur's commitment to GlucoGuard solidifies our path forward as we finalize the FDA Break Through Device (BTD) application,\" commented ADHC. \"The Arete Bioscience team, led by Kunal, is a major foundational component to streamlining the FDA approval process. We have assembled an all-star team as the final portion of the FDA (BTD) application is concluded.\"\r\nIn addition to the engineering work on the GlucoGuards prototype design, Dr. Sur will spear-head the review of other acquisition opportunities for ADHC, which is currently ongoing. Also, Dr. Sur will be coordinating future integration with Dexcom, GlucoGuards' Continuous Glucose Monitor \"CGM\" Development Partner.\r\nDr. Kunal Sur, PhD, is an experienced professional in the field of biomedical engineering, with a background in biotechnology and biochemical engineering, and is currently serving as the Managing Partner at Arete Biosciences, Inc. Prior to these roles, Kunal held various leadership positions at Roche, GenMark Diagnostics, Quidel and Hospira. Kunal earned their PhD and MS in Biomedical Engineering from Northwestern University, and a B. Tech in Biotechnology & Biochemical Engineering from the Indian Institute of Technology, Kharagpur.\r\nABOUT ARETE BIOSCIENCES, Inc.\r\nEnd-to-End Health Tech Product Development\r\naretebiosciences.com\r\nArete BioSciences, Inc. (\"Arete\") is a contact service org...